The latest Canadian Experience Class draw comes just a week after a 6,000-invite round, signalling strong focus on in-Canada ...

Jean Chatzky the CEO & Founder of HerMoney Media joins Smerconish to discuss the rise of millionaires, inflation, and what would be considered “wealthy” in 2025. California on track to break 75-year ...

Thinking about whether ePlus might be a hidden gem or fairly priced right now? You are definitely not alone, and there are some signals worth paying attention to. Despite a minor 1.7% slip over the ...

Google has released its annual Year in Search feature, which presents the summary of the year's most searched-for topics There are probably one millions ways to express love, and thousands of phrases ...

Curious how your retirement savings compare to other 58-year-olds? Here's how much the average American has saved in a 401(k) by age 58 and what to do if you're behind.

The Trump administration has agreed to inject up to $150 million into xLight, a semiconductor startup developing advanced chip-making technology, marking the third time the U.S. government has taken ...

Owners of high-value homes will be hit with a yearly mansion tax charge from April 2028, Rachel Reeves confirmed in today's Autumn Budget. Reeves claimed that the charge will make the tax system ...

Michael Glasheen, operations director of the National Security Branch at the FBI, called antifa the agency’s 'primary concern ...

After the endless speculation, the Budget finally arrived this week. Rachel Reeves seemed happy with her statement and Sir Keir Starmer has been out singing its praises, but was the Budget a diamond ...

Introduction Organized retail and cargo theft are public safety and consumer protection problems driven by a relatively small ...

The Federal Reserve just wrapped up its final meeting of 2025 with another rate cut, marking the third reduction this year. But this decision was far from straightforward, and Fed officials made it ...

Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as a mainstay of treatment for individuals living with blood ...